Zolpidem moa?

Question

Zolpidem moa?

Accepted Answer

Zolpidem – Mechanism of Action (MOA)

Aspect	Details
Drug class	Non‑benzodiazepine hypnotic (often called a “Z‑drug”)
Target	GABA_A receptor complex – specifically the benzodiazepine binding site on the α1 subunit
Binding characteristics	• High affinity for the α1 subunit, which is linked to sedative/hypnotic effects. • Lower affinity for α2/α3/α5 subunits (the ones associated with anxiolysis, muscle relaxation, and cognition).
Pharmacodynamic effect	• Binding increases the affinity of the receptor for GABA. • Enhances chloride ion influx into neurons → hyperpolarization → decreased neuronal excitability. • Net result: rapid onset of sleep (within ~15‑30 min), short duration (~1–2 h).
Clinical outcome	Induces sleep without significant anticonvulsant or muscle‑relaxant properties that benzodiazepines often have.
Key pharmacokinetics	• Rapid absorption; peak plasma concentration ≈ 1 h. • Short half‑life (≈ 1.5–2 h), so minimal next‑day residual effect. • Metabolized mainly by CYP3A4; some metabolites are active but much weaker.

Why it’s useful for insomnia

Selective hypnotic action: Because of its preference for α1, it produces sleep without much of the “muscle‑relaxation” or “anticonvulsant” side‑effects common to benzodiazepines.
Quick onset & short duration: Allows a patient to fall asleep quickly and reduces the risk of daytime somnolence.
Minimal withdrawal/abuse potential (in comparison to benzodiazepines): Though not risk‑free, it tends to be less problematic for short‑term use.

Quick take‑away

Zolpidem is a GABA_A receptor modulator that selectively enhances the action of GABA at the α1 subunit, producing a rapid, short‑lasting hypnotic effect ideal for treating insomnia.

Ask Questions, Get Industry Insights … Instantly

Recent Questions

Zolpidem moa?

Why it’s useful for insomnia

Quick take‑away